BridgeMD
Prevention study for Premature
Official title Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile
ClinicalTrials.gov ID: NCT06812507
What this study is testing
- What it's testing
- The objective of this study is to evaluate the general course and prognosis associated with different methods of placental transfusion (Intact umbilical cord milking, cut- umbilical cord milking and delayed cord clamping) in premature neonates over the first days of life
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 2. Healthy volunteers may be eligible.
You may be able to join if
- 1. Premature neonates ≤ 32 weeks gestational age regardless birth weight
- patients should be admitted to neonatal intensive care unit in the first day of life of life
You likely can't join if
- Exclusion Criteria: Patient with any of the following will be excluded:
- Major congenital anomalies (complex cyanotic heart disease, major central nervous system anomalies).
- Evidence of head trauma causing major intracranial hemorrhage.
- placental abnormalities like : abruptions, placenta previa or retroplacental hematoma.
- Cord accident, or avulsion at the time of delivery.
- Refusal to perform the intervention by the obstetrician
The study team makes the final eligibility decision.
Where it's taking place
- Alexandria, Egypt
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 minute to 2 minutes. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Alexandria, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.